INLYTA® (axitinib)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for INLYTA® (axitinib), indicated for advanced renal cell carcinoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 6: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 17: Clinical Safety and Efficacy
Slide 23: Drug Storage and Supply

Next hm-slideshow in Slides